Publications by authors named "Anne Orbo"

Claim this Profile
E
Expression of nuclear progesterone receptors (nPRs), membrane progesterone receptors (mPRs) and progesterone receptor membrane components (PGRMCs) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy.
Elise Thoresen Sletten, Natalia Smaglyukova, Anne Ørbo, Georg Sager

J Steroid Biochem Mol Biol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data on RT-qPCR assay of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) from human uterine endometrial tissue and cancer cells of the Uterine Cervix.
Natalia Smaglyukova, Elise Thoresen Sletten, Anne Ørbo, Georg Sager

Data Brief· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrauterine Progestin Therapy as a New Approach to Premalignant Endometrial Polyps: A Prospective Observational Study.
Elise Thoresen Sletten, Marit Arnes, Anne Beate Vereide, Anne Ørbo

Anticancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.
Elise Thoresen Sletten, Marit Arnes, Anne Beate Vereide, Anne Ørbo

Anticancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study.
Elise Thoresen Sletten, Marit Arnes, Lena Myreng Lysa, Bjorn Tg Moe, Bjorn Straume, Anne Orbo

Anticancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.
Anne Ørbo, Marit Arnes, Lena Myreng Lyså, Christer Borgfeldt, Bjørn Straume

Br J Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.
Anne Ørbo, Marit Arnes, Lena Myreng Lyså, Christer Borgfeldt, Bjørn Straume

Br J Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of PAX2 and PTEN Correlates to Therapy Response in Endometrial Hyperplasia.
Anne Ørbo, Marit Arnes, Lena Myreng Lyså, Bjørn Straume

Anticancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levonorgestrel-impregnated Intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study.
Marit Arnes, Bodil Hvingel, Anne Orbo

Anticancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased gene expression of the ABCC5 transporter without distinct changes in the expression of PDE5 in human cervical cancer cells during growth.
Tormod Eggen, Georg Sager, Thomas Berg, Birgitte Nergaard, Bjørn T G Moe

Anticancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of iNOS--a favourable prognostic marker for early-stage carcinoma of the uterine cervix.
Tormod Eggen, Georg Sager, Marit Arnes, Inger Pettersen, Anne Ørbo

Anticancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486).
Renathe Fjelldal, Bjørn T Moe, Anne Ørbo, Georg Sager

Anticancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system.
Anne Orbo, Marit Arnes, Inger Pettersen, Kurt Larsen, Karin Hanssen

Acta Obstet Gynecol Scand· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction.
Anne Ørbo, Turid Kaino, Marit Arnes, Kurt Larsen, Inger Pettersen

Acta Obstet Gynecol Scand· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Bjørn T Moe, Anne B Vereide, Anne Orbo, Ragnhild Jaeger, Georg Sager

Anticancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.
Bjørn G Moe, Anne B Vereide, Anne Orbo, Georg Sager

Anticancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa).
Anne Ørbo, Bjørn T Moe, Halvor Grønaas, Ruth H Paulssen

J Steroid Biochem Mol Biol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
Anne Ørbo, Marit Arnes, Christine Hancke, Anne Beate Vereide, Inger Pettersen

Gynecol Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone.
Ruth H Paulssen, Bjørn Moe, Halvor Grønaas, Anne Orbo

Steroids· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of early cervical cancer (FIGO Stages IA2, IB, and IIA) in northern Norway predicted by malignancy grading score and objective morphometric image analysis.
Tormod Eggen, Marit Arnes, Bjørn Moe, Bjørn Straume, Anne Orbo

Int J Gynecol Pathol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.
Anne Orbo, Målfrid Hanevik, Ragnhild Jaeger, Saskia Van Heusden, Georg Sager

Anticancer Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of latent endometrial precancers by progestin infiltrated intrauterine device.
Anne Ørbo, Cecil E Rise, George L Mutter

Cancer Res· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
Anne Beate Vereide, Turid Kaino, Georg Sager, Marit Arnes, Anne Ørbo

Gynecol Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system.
Jan P Baak, George L Mutter, Stanley Robboy, Paul J van Diest, Anne M Uyterlinde, Anne Orbo

Cancer· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Anne Beate Vereide, Turid Kaino, Georg Sager, Anne Ørbo,

Gynecol Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis